Intrinsic Value of S&P & Nasdaq Contact Us

Galexxy Holdings, Inc. GXXY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
8/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Galexxy Holdings, Inc. (GXXY) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 8/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
8/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
0/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — GXXY

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $0.00 $30.00 $-175.00 -583.3%
2020 $0.00 $20K $-161.23K -806.2%
2021 $0.00 $0.00 $-742.96K -
2022 $-0.09 $536.02K $-17.61M -3286.3%
2023 $-0.01 $1.06M $-1.34M -127.2%
2024 $-0.01 $118.48K $-2.98M -2517.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message